Lakhmir S. Chawla's most recent trade in Revelation Biosciences Inc was a trade of 2,261 Common Stock done at an average price of $1.9 . Disclosure was reported to the exchange on Feb. 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revelation Biosciences Inc | Lakhmir S. Chawla | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.85 per share. | 03 Feb 2026 | 2,261 | 12,158 | - | 1.9 | 4,183 | Common Stock |
| Revelation Biosciences Inc | Lakhmir S. Chawla | Director | Grant, award, or other acquisition of securities at price $ 0.90 per share. | 08 Jan 2026 | 41,981 | 57,667 | - | 0.9 | 37,783 | Common Stock |
| Revelation Biosciences Inc | Lakhmir S. Chawla | Director | Grant, award, or other acquisition of securities at price $ 1.28 per share. | 29 Oct 2025 | 15,625 | 15,686 | - | 1.3 | 20,000 | Common Stock |
| Revelation Biosciences Inc | Lakhmir S. Chawla | Director | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 181 | 181 | - | 3.9 | 700 | Common Stock |